EO Launches First-Ever Digital Health Platform Offering Affordable, Clinician-Guided Cannabis Care
Bridging the Cannabis Care Gap with Personalized, Evidence-Based Medicine and Clinical Oversight at ScaleBOSTON, Aug. 17, 2022 (GLOBE NEWSWIRE) --...
Day: August 17, 2022
Peggy’s Cove achieves top accessibility rating under the Rick Hansen Foundation Accessibility Certification™ program
Peggy's Cove (Nova Scotia), Aug. 17, 2022 (GLOBE NEWSWIRE) -- One of Nova Scotia’s most iconic attractions has achieved a...
Scilex Holding Company, a Sorrento Company, Announces Exclusive Product Distribution Agreement with CH Trading Group LLC to Expand Commercialization of ZTlido® across certain designated territories including Middle East and North Africa
PALO ALTO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a commercial biopharmaceutical company focused on developing...
Pure Extracts Delivers Its Largest Shipments to Launch its Newest Vape Product
VANCOUVER, British Columbia, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
Palisade Bio Announces First Patient Enrolled and Dosed in Pivotal Phase 3 Study Evaluating LB1148 for Postoperative Return of Bowel Function
CARLSBAD, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for...
Blue Water Vaccines Announces Exploration of Its Virus-Like Particle (VLP) Platform for Use in Monkeypox Vaccine Candidate
CINCINNATI, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a...
Oncotelic Participating at Biotechgate Digital Partnering
AGOURA HILLS, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), developer of treatments...
Oyster Point Pharma Announces TYRVAYA® To Be Covered By the Largest Medicare Pharmacy Benefit Manager
PRINCETON, N.J., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), (“Oyster Point Pharma”, or “the Company”),...
Enlivex Receives Israeli Ministry of Health Approval for the Initiation of a Phase I/II Trial Evaluating Allocetra™ Alone and in Combination with a PD1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors
Trial builds on encouraging preclinical studies conducted in collaboration with Yale Cancer Center that showed a substantial, statistically significant survival...
Magenta Therapeutics Appoints Michael Vasconcelles, M.D. to the Board of Directors
CAMBRIDGE, Mass., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines designed...
Coloplast Finance B.V. – 9M Interim Financial Report 2021/2022
Coloplast B.V. - Announcement no. 02/2022 - Interim Financial Report, 9M 2021/2022 9M 2021/22 Interim financial results, 9M 2021/22...
CloudMD Provides Business Update on Customer Momentum
VANCOUVER, British Columbia, Aug. 17, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH)...
Kraig Biocraft Laboratories Expands Operational Footprint in Vietnam
ANN ARBOR, Mich., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the...
Tilray Medical Bolsters Market Leading Position in Europe With Market Authorization in Poland
Polish Ministry of Health Approves Tilray Branded Medical Cannabis for Pharmaceutical Distribution in Addition to Wholesale ApprovalLEAMINGTON, Ontario and CANTANHEDE,...
Kamada Reports Second Quarter and First Half 2022 Financial Results; Significant Growth Driven by Multiple Catalysts Expected in Second Half of 2022; Reiterates 2022 Revenue and Profitability Guidance
Second Quarter 2022 Revenues were $23.6 Million; First Half 2022 Revenues of $51.7 Million Increased 5% Year-Over-YearFirst Half 2022 Adjusted...